Fresenius Medical Care KGAA ST (FMEG)

56.080
-0.220(-0.39%)
  • Volume:
    385,545
  • Bid/Ask:
    55.910/55.980
  • Day's Range:
    55.700 - 57.100
  • Type:Equity
  • Market:Germany
  • ISIN:DE0005785802
  • WKN:578580

FMEG Overview

Prev. Close
56.08
Day's Range
55.7-57.1
Revenue
-
Open
56.98
52 wk Range
50.98-71.14
EPS
3.31
Volume
385,545
Market Cap
16.39B
Dividend (Yield)
1.35
(2.40%)
Average Volume (3m)
605,068
P/E Ratio
18.25
Beta
0.9
1-Year Change
-15.77%
Shares Outstanding
293,027,279
Next Earnings Date
01 Aug 2022
What is your sentiment on Fresenius Medical Care?
or
Market is currently closed. Voting is open during market hours.

Fresenius Medical Care KGAA ST News

  • Fresenius Medical Care Earnings, Revenue beat in Q1
    • ByInvesting.com-

    Investing.com - Fresenius Medical Care reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. Fresenius Medical Care...

  • Fresenius Medical Care Earnings, Revenue miss in Q3
    • ByInvesting.com-

    Investing.com - Fresenius Medical Care reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Fresenius Medical...

Fresenius Medical Care KGAA ST Company Profile

Fresenius Medical Care KGAA ST Company Profile

Employees
122909
Market
Germany

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong BuySellStrong SellStrong SellStrong Sell
SummaryNeutralSellStrong SellStrong SellStrong Sell